Results 131 to 140 of about 15,127 (212)

Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study. [PDF]

Dermatol Res Pract
Nasrollahi SA, Fattahi M, Lotfali E, Naeimifar A, Amiri F, Ghaderi A, Tamimi P, Zamani S, Khamesipoor A, Firooz A.   +9 more
europepmc   +1 more source

Antifungal efficacy of a novel nitric oxide releasing solution in the presence of keratin. [PDF]

Front Cell Infect Microbiol
Long L, Eltohky A, Sewake J, Miller C, Martins J, Teskey SJL, Ghannoum M, McCormick TS.   +7 more
europepmc   +1 more source

Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. [PDF]

, 1994
Anonymous, British Society for Antimicrobial Chemotherapy Working Party, Fan-Havard, Fox, Galgiani, Johnson, Kitchen, Korting, Korting, Korting, Laine, McCarthy, Ollert, Rogers, Samaranayake, Smith, Warnock, Willocks, Wit   +18 more
core   +1 more source

Terbinafine-induced liver injury with isolated serum alkaline phosphatase elevation: A case report and literature review. [PDF]

J Int Med Res
Liu YH, Guo Y, Xu H, Feng H, Pan F.
europepmc   +1 more source

Antibiofilm activity of terbinafine, itraconazole and their combination against Sporothrix brasiliensis yeast-like form's biofilms. [PDF]

Braz J Microbiol
Sprenger AB, Svidzinski TIE, Geraldo MR, Silva AB, Sant Ana LAM, Cognialli RCR, Razzolini E, Santos GD, Vicente VA, Queiroz-Telles F.   +9 more
europepmc   +1 more source

Global Emergence of <i>Trichophyton mentagrophytes</i> ITS Genotype VIII (<i>Trichophyton indotineae</i>): A Scoping Review of Epidemiology, Clinical Features, and Antifungal Resistance, 2019-2025. [PDF]

Infect Drug Resist
Gupta AK, Liddy A, Wang T, Kaplan B, Shemer A, Talukder M.   +5 more
europepmc   +1 more source

Terbinafine [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Purification and structural characterization of an anti-<i>Trichophyton</i> compound produced by <i>Auricularia heimuer</i> mycelium. [PDF]

Mycoscience
Hirata T, Song S, Seki K, Taniguchi M, Ishihara A, Ichiyanagi T, Aimi T.   +6 more
europepmc   +1 more source

Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical Response. [PDF]

Open Forum Infect Dis
Kovac V, Hammond SP, Issa NC, Liakos A, Little JS, Sherman AC, Baden LR, Woolley AE.   +7 more
europepmc   +1 more source

<i>In silico</i> identification of isosilybin a targeting squalene epoxidase as an antifungal adjuvant with <i>in vitro</i> validation against azole-resistant <i>Candida</i> and emerging yeasts. [PDF]

Front Cell Infect Microbiol
Mundhe AK, Rajkumari R.
europepmc   +1 more source